Potential Role of Seaweed Polyphenols in Cardiovascular-Associated Disorders
Metadatos
Mostrar el registro completo del ítemEditorial
MDPI
Materia
Cardiovascular diseases Hypertension Immune response Metabolic syndrome Seaweed polyphenols
Fecha
2018-07-28Referencia bibliográfica
Gómez Guzmán, M. Potential Role of Seaweed Polyphenols in Cardiovascular-Associated Disorders. Mar. Drugs 2018, 16, 250; doi:10.3390/md16080250.
Patrocinador
This work was supported by the Junta de Andalucía (CTS 164) and by the Spanish Ministry of Economy and Competitiveness (AGL2015-67995-C3-3-R) with funds from the European Union. The CIBER-EHD is funded by the Instituto de Salud Carlos III.Resumen
The beneficial effects of various polyphenols with plant origins on different
cardiovascular-associated disorders, such as hypertension, diabetes mellitus type 2 and metabolic
syndrome are well known. Recently, marine crude-drugs are emerging as potential treatments in
many noncommunicable conditions, including those involving the cardiovascular system. Among the
active compounds responsible for these activities, seaweed polyphenols seem to play a key role.
The aim of the present review is to summarise the current knowledge about the beneficial effects
reported for edible seaweed polyphenols in the amelioration of these prevalent conditions, focusing
on both preclinical and clinical studies. This review will help to establish the basis for future studies
in this promising field.